The Liver Meeting 2019-Current Status of U.S. and Global Drug Access

Current Status of U.S. and Global Drug Access

Video Transcription

Video Summary

The speaker discussed the challenges and successes in market access for hepatitis C drugs, reflecting on past mistakes and potential future strategies for hepatitis B. They highlighted the global disparities in drug access and the need for creative solutions to improve affordability and availability, sharing insights from different countries and regions. The speaker also addressed issues in the US healthcare system, such as drug pricing, reimbursement barriers, and treatment access in prisons and tribal nations. They emphasized the importance of advocating for accessible healthcare and promoting competition while maintaining physician choice in treatment selection. The session concluded with discussions on generic drug penetration and the evolving landscape of hepatitis drug access.

Asset Caption

Presenter: Camilla S. Graham

Keywords

hepatitis C drugs

market access

global disparities

drug pricing

healthcare system

generic drug penetration